Significant publications on infectious diseases pharmacotherapy in 2011

Truc T. Tran, Nicholas D. Beyda, Lauren R. Biehle, Jessica E. Cottreau, Kelly Echevarria, William L. Musick, Katherine K. Perez, Amy N. Schilling

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Abstract

Purpose. Important articles on topics pertinent to infectious diseases (ID) pharmacotherapy published in prominent peerreviewed journals in 2011 are summarized. Summary. Pharmacists, physicians, and researchers from the Houston Infectious Diseases Network were asked to nominate articles published in 2011 that they perceived as having a significant impact on the field of ID pharmacotherapy. The resulting list, comprising 10 articles related to human immunodeficiency virus (HIV) disease or acquired immune deficiency syndrome (AIDS) and 38 articles on a broad range of other ID-related topics, was sent to members of the Society of Infectious Diseases Pharmacists (SIDP) for evaluation via an Internet survey. The survey participants were asked to select 10 articles from the list of general ID articles and 1 article from the HIV- or AIDS-related articles that they viewed as having the most impact on the field. Of the 328 SIDP members surveyed, 120 (37%) ranked the non-HIV-related papers and 55 (17%) ranked the HIV-related papers. The 12 highest-ranked items - including 3 guidelines - are summarized here. Conclusion. Due to the increasing number of articles published each year, it is difficult to maintain a current knowledge of significant publications in the field of ID pharmacotherapy. This review of the key articles in 2011 may be helpful to the nonspecialist clinician by lessening this burden.

Original languageEnglish (US)
Pages (from-to)1671-1681
Number of pages11
JournalAmerican Journal of Health-System Pharmacy
Volume69
Issue number19
DOIs
StatePublished - Oct 1 2012

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy

Fingerprint

Dive into the research topics of 'Significant publications on infectious diseases pharmacotherapy in 2011'. Together they form a unique fingerprint.

Cite this